Chen Zhiping

Age: 50

Residence: Shenzhen, China — a global tech and manufacturing hub, offering proximity to Smoore’s operations and supply chain partners.

Citizenship: China — reflects his deep roots in the domestic market and alignment with national industrial policy.

Marital Status: Married — personal stability often correlates with long-term business leadership in founder-led firms.

Education: Master’s from China Europe International Business School (CEIBS), a top-tier MBA program known for producing China’s business elite. Bachelor’s in Arts/Economics from Tongji University, suggesting a multidisciplinary foundation in both humanities and quantitative analysis.

Professional Network: Alumni ties to CEIBS connect Chen to a powerful cohort of Chinese entrepreneurs, including Richard Liu (JD.com) and Fisher Zhang. These relationships may facilitate strategic partnerships, investor access, and policy insights.

Legacy: As China’s first vaping billionaire, Chen represents a new generation of tech-enabled manufacturers who turned niche consumer products into global supply chain powerhouses. His 2024 pivot into health and beauty tech signals an evolution from controversy-driven markets to science-backed applications — a move that may define his long-term legacy.

Chen Zhiping’s net worth, as of April 1, 2025, is reported to be approximately $1.2 billion, placing him at #1281 globally on the Billionaires list. This valuation is primarily derived from his ownership stake in Smoore International Holdings, the company he founded and leads as chairman and CEO. Smoore’s public listing on the Hong Kong Stock Exchange in 2020 marked a pivotal moment in Chen’s wealth accumulation, with the IPO raising over $900 million and providing public market liquidity to his equity holdings. His position as China’s first vaping billionaire reflects both the scale of the global e-cigarette market and the strategic positioning of Smoore as a key supplier to major tobacco corporations including Japan Tobacco, British American Tobacco, and NJOY.

Net worth estimates for private company founders like Chen Zhiping are inherently dynamic and subject to market volatility, regulatory shifts, and corporate performance. Smoore’s valuation is tied to its revenue streams from vaping components, which are sensitive to global regulatory environments—particularly in markets like the United States and the European Union where vaping regulations have tightened in recent years. Additionally, the company’s 2024 pivot into inhalation therapy and beauty treatment introduces new revenue potential but also carries execution risk. As such, Chen’s net worth may fluctuate significantly based on investor sentiment toward these new verticals and the broader acceptance of vaping-related technologies in healthcare and consumer wellness sectors.

Unlike traditional industrial or tech billionaires whose wealth is often diversified across multiple assets or companies, Chen’s fortune remains heavily concentrated in Smoore. This concentration amplifies both upside potential and downside risk. For instance, if Smoore successfully scales its inhalation therapy division and secures regulatory approvals in key markets, Chen’s net worth could rise sharply. Conversely, if regulatory crackdowns on vaping intensify or if the company’s new ventures fail to gain traction, his wealth could contract rapidly. Investors and analysts typically monitor Smoore’s quarterly earnings, R&D expenditures, and partnerships with pharmaceutical or beauty firms to gauge the trajectory of Chen’s personal fortune.

It is also worth noting that Chen’s net worth does not include potential off-balance-sheet assets such as private investments, real estate holdings, or family trusts, which are not publicly disclosed. His residence in Shenzhen, China, and his status as a self-made entrepreneur suggest a lifestyle that may reflect both frugality and strategic reinvestment of capital into the business. His educational background—a Bachelor of Arts/Economics from Tongji University and a Master’s from China Europe International Business School—indicates a formal grounding in economic theory and international business, which likely informed his approach to scaling Smoore into a global supplier.

Chen Zhiping’s wealth trajectory is closely aligned with the rise of the global e-cigarette industry and the evolution of Smoore International Holdings from a private manufacturer to a publicly traded multinational corporation. His journey to billionaire status began in the early 2010s when he recognized the potential of electronic nicotine delivery systems (ENDS) as a disruptive force in the tobacco industry. At the time, the vaping market was nascent, fragmented, and largely unregulated, offering significant opportunities for vertically integrated suppliers who could deliver high-quality, scalable components to emerging brands.

By 2015, Smoore had established itself as a key player in the supply chain, providing atomizers, cartridges, and other critical components to major international tobacco companies. This strategic positioning allowed Chen to capitalize on the global expansion of vaping, particularly in markets where traditional tobacco companies were seeking to diversify their product portfolios in response to declining cigarette sales. The company’s ability to innovate in heating technology and device design gave it a competitive edge, enabling it to secure long-term contracts with clients such as Japan Tobacco and British American Tobacco.

The turning point in Chen’s wealth accumulation came in 2020, when Smoore went public on the Hong Kong Stock Exchange. The IPO raised more than $900 million, valuing the company at approximately $15 billion at the time. Chen’s stake in the company, estimated to be in the range of 20-30% prior to the offering, translated into a personal net worth that catapulted him into the ranks of China’s top billionaires. His inclusion on the China Rich List at #55 in 2021 underscored the magnitude of his success and the market’s confidence in Smoore’s growth potential.

However, the years following the IPO were marked by increased regulatory scrutiny and market volatility. In 2021 and 2022, several major markets—including the United States and the European Union—introduced stricter regulations on vaping products, leading to a decline in Smoore’s stock price and, by extension, Chen’s net worth. The company’s valuation dropped significantly from its IPO peak, reflecting investor concerns about the sustainability of the vaping business model in a more regulated environment. Chen’s personal wealth, therefore, experienced a period of contraction during this time, although he remained a billionaire due to the continued strength of Smoore’s core business and its expanding client base.

In 2024, Chen and Smoore embarked on a strategic diversification initiative, expanding the company’s technology into inhalation therapy and beauty treatment. This move was designed to mitigate regulatory risk by leveraging the company’s expertise in aerosol delivery systems for non-nicotine applications. The inhalation therapy segment targets the pharmaceutical industry, with potential applications in the delivery of medications for respiratory conditions, while the beauty treatment division explores the use of aerosolized formulations for skincare and cosmetic enhancement. These new ventures represent a significant shift in Smoore’s business model and could serve as a catalyst for renewed growth in Chen’s net worth if they gain market acceptance.

Looking ahead, Chen’s wealth history will likely be shaped by the success of these diversification efforts, the regulatory landscape for vaping and inhalation technologies, and the broader macroeconomic environment. If Smoore can successfully transition into a multi-industry technology platform, Chen’s net worth may experience a resurgence. Conversely, if the company struggles to adapt to changing market conditions or faces further regulatory headwinds, his wealth could remain under pressure. As of 2025, Chen’s position at #1281 on the global billionaires list reflects a more modest valuation compared to his peak in 2021, but it also highlights the resilience of his business model and his ability to navigate complex market dynamics.

Riaz Valani — Related by origin of wealth: E-cigarettes. Valani is a key figure in the global vaping industry, often cited for his role in shaping distribution and regulatory strategies in Western markets.

Fisher Zhang — Related by education: China Europe International Business School. Zhang is a fellow alumnus and likely shares Chen’s strategic mindset, though his specific industry focus is not disclosed.

Li Ping — Related by education: China Europe International Business School. Another peer from Chen’s MBA cohort, suggesting a network of business leaders with similar training and operational philosophies.

Richard Liu — Related by education: China Europe International Business School. Liu is a prominent Chinese entrepreneur, known for founding JD.com, indicating Chen’s association with top-tier business leaders in China’s tech ecosystem.

Chen Zhiping’s early life and educational background provide insight into the foundation of his entrepreneurial success. Born in China, Chen pursued higher education at Tongji University, where he earned a Bachelor of Arts/Economics degree. This academic foundation equipped him with a strong understanding of economic principles and market dynamics, which would later prove invaluable in navigating the complexities of the global vaping industry. His decision to study economics suggests an early interest in business and finance, as well as a strategic mindset focused on understanding how markets function and how value is created.

After completing his undergraduate studies, Chen furthered his education at the China Europe International Business School (CEIBS), where he obtained a Master’s degree. CEIBS is one of China’s most prestigious business schools, known for its rigorous curriculum and emphasis on international business practices. Studying at CEIBS likely exposed Chen to global business trends, corporate governance models, and strategic management frameworks that would inform his leadership style at Smoore. The school’s focus on bridging Eastern and Western business practices may have also influenced Chen’s ability to position Smoore as a global supplier to international tobacco companies.

While specific details about Chen’s early career or family background are not publicly disclosed in the provided data, his educational trajectory suggests a deliberate and ambitious path toward business leadership. His choice to pursue advanced education in business and economics, rather than a technical or engineering field, indicates a focus on strategy, management, and market positioning—skills that would be critical in building Smoore into a multinational corporation. The fact that he is listed as a self-made billionaire further underscores his entrepreneurial drive and ability to identify and capitalize on emerging market opportunities.

Chen’s early life also reflects the broader context of China’s economic transformation in the late 20th and early 21st centuries. As China opened up to global markets and embraced private enterprise, a new generation of entrepreneurs emerged, leveraging education, innovation, and global connections to build successful businesses. Chen’s story is emblematic of this generation—individuals who combined formal education with practical business acumen to create value in rapidly evolving industries. His residence in Shenzhen, a city known for its entrepreneurial spirit and technological innovation, further situates him within a dynamic ecosystem that fosters business growth and risk-taking.

Chen Zhiping’s path to wealth is a case study in identifying a high-growth niche, building a scalable supply chain, and leveraging global market opportunities. His journey began with the recognition that the emerging e-cigarette industry required reliable, high-quality components—a need that was not being adequately met by existing manufacturers. Rather than competing in the crowded space of consumer-facing vaping brands, Chen chose to focus on the upstream supply chain, positioning Smoore as a B2B supplier to major tobacco companies. This strategic decision allowed him to avoid the regulatory and marketing challenges faced by consumer brands while capitalizing on the growing demand for vaping products.

The foundation of Chen’s wealth was laid in the early 2010s, when he established Smoore as a manufacturer of vaping components. The company’s early success was driven by its ability to innovate in heating technology and device design, which gave it a competitive edge in a rapidly evolving market. By securing contracts with major tobacco companies such as Japan Tobacco and British American Tobacco, Chen ensured a steady stream of revenue and a strong foothold in the global market. These partnerships were critical in scaling Smoore’s operations and establishing its reputation as a reliable supplier.

The next major milestone in Chen’s path to wealth was the 2020 IPO of Smoore on the Hong Kong Stock Exchange. The IPO raised more than $900 million and valued the company at approximately $15 billion, making Chen a billionaire overnight. His ownership stake in the company, estimated to be in the range of 20-30% prior to the offering, translated into a personal net worth that placed him among China’s top 100 wealthiest individuals in 2021. The IPO not only provided liquidity for Chen’s equity holdings but also enhanced Smoore’s brand recognition and credibility in the global market.

However, Chen’s path to wealth has not been without challenges. The years following the IPO were marked by increased regulatory scrutiny and market volatility, which led to a decline in Smoore’s stock price and, by extension, Chen’s net worth. In response, Chen and Smoore embarked on a strategic diversification initiative in 2024, expanding the company’s technology into inhalation therapy and beauty treatment. This move was designed to mitigate regulatory risk by leveraging the company’s expertise in aerosol delivery systems for non-nicotine applications. The inhalation therapy segment targets the pharmaceutical industry, with potential applications in the delivery of medications for respiratory conditions, while the beauty treatment division explores the use of aerosolized formulations for skincare and cosmetic enhancement.

Chen’s path to wealth also reflects his ability to adapt to changing market conditions and pivot strategically when necessary. While the vaping industry remains a core part of Smoore’s business, the company’s expansion into new verticals demonstrates a forward-looking approach that seeks to diversify revenue streams and reduce dependence on a single market. This diversification strategy is likely to play a key role in the future trajectory of Chen’s net worth, as it positions Smoore to capitalize on emerging opportunities in healthcare and consumer wellness.

Looking ahead, Chen’s path to wealth will likely be shaped by the success of these diversification efforts, the regulatory landscape for vaping and inhalation technologies, and the broader macroeconomic environment. If Smoore can successfully transition into a multi-industry technology platform, Chen’s net worth may experience a resurgence. Conversely, if the company struggles to adapt to changing market conditions or faces further regulatory headwinds, his wealth could remain under pressure. As of 2025, Chen’s position at #1281 on the global billionaires list reflects a more modest valuation compared to his peak in 2021, but it also highlights the resilience of his business model and his ability to navigate complex market dynamics.

Chen Zhiping’s empire is anchored in Smoore International Holdings, a global leader in vaping device components and a pioneer in China’s e-cigarette supply chain. Unlike consumer-facing brands, Smoore operates as a B2B powerhouse, supplying major tobacco conglomerates including Japan Tobacco, British American Tobacco, and NJOY. This positioning grants it insulation from direct consumer backlash while exposing it to the volatility of its clients’ regulatory and market strategies. The company’s 2020 Hong Kong IPO, which raised over $900 million, signaled global investor confidence in its manufacturing scale and technological edge — particularly in ceramic coil atomization, a proprietary innovation that became an industry standard. Smoore’s pivot in 2024 into inhalation therapy and beauty tech reflects a strategic diversification to mitigate sector-specific risks, though these new verticals remain nascent and unproven in revenue contribution.

Chen Zhiping’s leadership is defined by operational precision and technological pragmatism. As both chairman and CEO, he maintains tight control over R&D and supply chain logistics, a structure that enables rapid iteration but risks over-reliance on his personal vision. His background in economics and business administration from Tongji University and China Europe International Business School informs a data-driven, efficiency-first management style. Chen’s decision to diversify into medical and beauty inhalation tech suggests a long-termist mindset, though the execution of such pivots demands cultural and regulatory fluency beyond China’s borders — a challenge for a leader whose core expertise lies in manufacturing and component supply. His low public profile contrasts with the high-stakes nature of his industry, indicating a preference for behind-the-scenes influence over media visibility.

Smoore’s capital allocation strategy has prioritized R&D and vertical integration, with significant investment in proprietary atomization technology and manufacturing automation. The $900 million IPO proceeds were largely reinvested into expanding production capacity and global logistics infrastructure, particularly in Southeast Asia and Europe, to hedge against U.S.-China trade friction. The 2024 diversification into inhalation therapy and beauty tech represents a calculated bet on adjacent markets with regulatory tailwinds — medical devices and cosmeceuticals — though these require substantial upfront investment and longer ROI horizons. Dividend policy remains conservative, reflecting the company’s growth-phase status and the need to retain capital for innovation and compliance. Chen’s capital discipline is evident in Smoore’s lean SG&A and high gross margins, but the concentration in vaping-related revenue remains a structural vulnerability.

Chen Zhiping’s empire faces acute regulatory and reputational risks. The global vaping industry is under increasing scrutiny from health authorities, with bans or restrictions in over 30 countries, including India, Thailand, and parts of the U.S. Smoore’s B2B model offers some insulation, but its clients’ regulatory exposure — particularly in the U.S. and EU — could trigger supply chain disruptions or contract renegotiations. Geopolitical risk is elevated: Smoore’s reliance on Chinese manufacturing and export channels makes it vulnerable to U.S. sanctions or tariffs targeting “dual-use” technologies. Reputational risk is amplified by the association with tobacco giants, despite Smoore’s claims of harm reduction. The company’s 2024 pivot into medical inhalation tech is a defensive maneuver, but regulatory approval timelines and market acceptance remain uncertain. Governance risks include founder dominance and limited board independence, which could hinder strategic agility in crisis scenarios.

Chen Zhiping’s philanthropic footprint is minimal and largely unpublicized, consistent with the low-profile ethos of many Chinese manufacturing billionaires. Unlike peers who leverage philanthropy for soft power or brand rehabilitation, Chen has not established a foundation or made high-profile donations. This absence may reflect strategic caution — avoiding association with controversial causes — or simply a focus on business continuity over public image. As Smoore expands into medical and beauty tech, philanthropic alignment with health or wellness initiatives could become a reputational asset, particularly in Western markets. However, without proactive engagement, Chen risks being perceived as detached from the social consequences of his core business, especially as vaping-related health debates intensify globally.

Chen Zhiping’s political influence is indirect but structurally embedded in China’s industrial policy. Smoore’s dominance in vaping tech aligns with Beijing’s push for high-value manufacturing and export-led growth, granting it implicit state support in the form of favorable regulatory treatment and access to export incentives. Chen’s ties to China Europe International Business School — a hub for elite business and policy networks — suggest access to influential circles, though he avoids overt political engagement. The company’s expansion into medical inhalation tech may attract state interest as China seeks to reduce dependence on foreign medical device suppliers. However, Chen’s exposure to U.S. and EU regulatory regimes creates a geopolitical tightrope: any perceived alignment with Chinese state interests could trigger backlash in Western markets, while distancing himself risks alienating domestic stakeholders.

Chen Zhiping’s legacy will be defined by his role in transforming China into a global hub for vaping technology — a sector that blends consumer electronics, regulatory arbitrage, and public health controversy. His success in building Smoore into a billion-dollar B2B supplier for global tobacco giants marks a rare case of Chinese manufacturing excellence in a Western-dominated industry. The 2024 pivot into medical and beauty tech could redefine his legacy as a tech innovator rather than a vaping enabler, but only if these ventures achieve scale and regulatory approval. His low public profile and lack of philanthropic branding may limit his cultural impact, but his influence on China’s tech-manufacturing ecosystem — particularly in Shenzhen — is likely to endure. The durability of his legacy hinges on Smoore’s ability to navigate regulatory headwinds and transition beyond its vaping roots.

• Profile: Chen Zhiping —
• Smoore International Holdings Investor Relations — https://www.smoore.com
• HKEX IPO Filing (2020) — Hong Kong Stock Exchange
• China Europe International Business School Alumni Network